FdaApplication
ANDA 218851
Identifiers
- fda_app_no: ANDA218851
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2026-03-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APREPITANT | APREPITANT | 32MG/4.4ML (7.2MG/ML) | EMULSION;INTRAVENOUS |
1 product